🔎 Trials Near Me

Gara Jalqabaatti › Melanoma › California › San Diego

Qorannoo klinikaalii Melanoma San Diego, CA keessatti

Qorannoo 18 Melanoma f San Diego fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

DESTINY-PANTUMOUR04

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Research Site, San Diego
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Namoota walitti qabaa jiraSadarkaa 3
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 75 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07068074

Pan-tumor MRD Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Medical Oncology Associates of San Diego (MOASD), San Diego
  • Medical Oncology Associates of San Diego, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06605404

Intratumoral N17350 in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07339176

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Namoota walitti qabaa jiraSadarkaa 2
  • Sharp Memorial Hospital, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of California, San Diego, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of California-San Diego, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07287917

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of California San Diego, Moores Cancer Center, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT04913285

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT05896839

Project: Every Child for Younger Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Rady Children's Hospital - San Diego, San Diego
  • Naval Medical Center -San Diego, San Diego
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Namoota walitti qabaa jiraSadarkaa 2
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT04598009

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 3
  • UCSD Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06581406

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06956690

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Namoota walitti qabaa jiraQorannoo ilaalaa
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Ama-2026 · NCT06887348

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, La Jolla · Miili 11 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sharp Memorial Hospital, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2025 · NCT05086692

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Gur-2024 · NCT04282044

Qorannoo Melanoma magaalota biroo keessatti

Qorannoo biroo San Diego keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.